Market Analysis - Annual Report -April, 2020- Tylosin Tartrate
Analyst: Murphy
1.Overview of the Current Market Situation
Tylosin Tartrate prices fell in April. In April, the supplier's operating rate was good, and the adverse effects of the epidemic on the factory were basically eliminated. The backlog of factory orders has dropped, TAIYICIN has delivered on time, and there is a small amount of inventory. The low-priced orders of LUKANG part have been delivered one after another, and for new orders,ETD is about in mid-May. Qilu is currently suspending quotations and expected to resume in early May.
The international terminal part has inventory, and traders should also have inventory at this stage, but the quantity is not large. At present, the price is still at a high level. If there is no urgent demand, the market transaction volume is not much. On the demand side, due to the global impact of the epidemic, some of the foreign end customers stopped production and reduced their production,there was less urgent demand,but in China domestic demand was better and more stable.
Some traders got the goods from the previous low-price orders, control some of the pricing power, comprehensive consideration of the factory, the market price has been reduced, international buyers actively understand the market information, but the actual demand is still not much. Therefore, the price of Tylosin Tartrate decreased in April due to various factors, but it has remained at a high level.

2.Manufacturer Price and Production Situation Statistics
|
Factory Name |
Quotation (USD/KG) |
Change (from last week) |
Plant capacity |
|
LUKANG |
27.8 |
Decline |
200MT/MON |
|
YAIYICIN |
28.5 |
Decline |
100MT/MON |
|
QILU |
/ |
/ |
120MT/MON |

- 3.Forecast of the Future Market Situation
|
Influential Factors |
Overview |
Price Trend |
|
Factory operating rate, inventory and cargo situation |
In May, the factory operating rate was normal. It is expected that both TAIYICIN and LUKANG can ship on time. QILU is expected to resume quotation in early or mid of May.Traders still have some inventory to clear. |
Decline |
|
Market Demand |
The market demand is almost the same as in April. The international market is affected by the epidemic, and end customers cut production and stop production. Low demand. |
Stable |
|
Market Sentiment |
Since late April, the market for tylosin tartrate has declined. In addition to urgent needs in the international market, most buyers are in a wait-and-see state. |
Decline |
|
Factory determination to raise prices |
The manufacturer's low-price orders are expected to be delivered in May. There were few new orders in April. In summary, the factory is more likely to cut prices and take orders. However, manufacturers need to give traders a period of time to consume inventory, so prices should be confirmed before mid-May. |
Decline |
|
Upstream raw materials |
The upstream raw materials are agricultural by-products, and its price fluctuations have little effect on tylosin tartrate. |
Increase |
|
Industry event |
/ |
/ |
|
In conclusion |
In May, the market operating rate was normal. There will be a small amount of low-priced inventory on the market. International terminal customers and traders mostly focus on understanding the market. In order to clear domestic stocks, domestic producers will also stabilize prices at a high level for some time. The price of tylosin tartrate is expected to stabilize at a high level in May and then decrease slightly. |
Decline |
2026-07-29
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
India's PV Community Comes Together at the 6th Edition Drug Safety Symposium 2026 – India Chapter to Shape the Future of Patient Safety
-
The project of fine chemicals with 4000 t/a Tebuconazole and Diflufenican is to be built
-
Pharmaconex 2022
-
Market Analysis of Domestic Veterinary Drug Raw Materials in the 34th Week of 2022
-
The Veterinary Drug Industry is Facing a Period of Opportunity for Change, and Leading Animal Health Companies are Expected to Grow Rapidly
-
Analysis of China's Veterinary Drug Raw Material Market in the 32nd Week of 2022(1)
-
Analysis of the Domestic Veterinary Drug Raw Material Market in the 28th Week of 2022
-
CPHI Korea 2022
-
Shandong Pharmaceutical Companies Grab Over $1 Billion of Antithrombotic Drugs for The First Imitation, Original Research Drugs Soared 5527%
-
ECHEMI International Trade Business School Bangladesh Pharmaceutical Summary
Recommend Reading
-
West Asia Tensions Squeeze Pharma Raw Materials
-
Steel in the Hourglass: Germany’s “Protect-Steel” Proposal and the Green Calculation Behind It
-
FSANZ Advances Caffeine Permission Changes
-
Lilly Eyes Fast-Track Approval for Oral Weight-Loss Drug in U.S.
-
Natural Color Claims Get Easier
-
This week, the cyclohexanone market in Shandong, China, has been on a downward trend
-
This week, the market price of pure benzene in China rose slightly (8.4-8.8)
-
This Week's PVC Prices Show Narrow Fluctuations (8.4-8.8) in China
-
Supply Phase Reduction, Acrylonitrile Market Probes Upward
-
In April, China's gasoline and diesel market trends declined
- Hot Searches
- tirzepatide peptide 30mg for sale
- where can i buy retatrutide near me
- poly diallyldimethylammonium chloride
- flunarim
- n-isopropylbenzylamine for sale
- red 167
- chemsynthesis chemical database
- polyvinyl alcohol films market
- ammonium nitrate prills
- sulfuric acid price per litre
- methanol sds
- specialty chemical products